ALI ASIF (Chief Financial Officer) sold 9.9% of their position (8.59K shares) of PROTAGONIST THERAPEUTICS, INC on the open market
Open‑market sale worth $708.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/21/2026ACC: 0001104659-26-005440
Officer· Chief Financial Officer
Since Apr 2022
-8.59K
Net shares
Net seller
$708.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.59K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.59K
Price / share
$82.48
Trade value
$708.34K
% of position
9.9%
1/20/2026
86.67K→78.08K
Total
Net shares
−8.59K
Net value
-$708.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/20/2026 | S · Sale | −8.59K | $82.48 | $708.34K | 9.9% | 86.67K | 78.08K |
| Total | −8.59K | -$708.34K | ||||||
Derivative Transactions0
No derivative transactions reported